Conceptual, Regulatory and Strategic Imperatives in the Early Days of EEG-Based Biomarker Validation for Neurodevelopmental Disabilities

Biological treatment development for syndromal neuropsychiatric conditions such as autism has seen slow progress for decades. Speeding drug discovery may result from the judicious development and application of biomarker measures of brain function to select patients for clinical trials, to confirm t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ewen, Joshua B., Sweeney, John A., Potter, William Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712089/
https://www.ncbi.nlm.nih.gov/pubmed/31496945
http://dx.doi.org/10.3389/fnint.2019.00045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712089/
https://www.ncbi.nlm.nih.gov/pubmed/31496945
http://dx.doi.org/10.3389/fnint.2019.00045

Ejemplares similares